成体神经干细胞中核孔蛋白 153 的缺乏定义了 AD 小鼠模型中的病理蛋白网络特征和神经发生缺陷。
Nucleoporin 153 deficiency in adult neural stem cells defines a pathological protein-network signature and defective neurogenesis in a mouse model of AD.
发表日期:2024 Sep 03
作者:
Claudia Colussi, Alessia Bertozzi, Lucia Leone, Marco Rinaudo, Raimondo Sollazzo, Federica Conte, Elena Paccosi, Luca Nardella, Giuseppe Aceto, Domenica Donatella Li Puma, Cristian Ripoli, Maria Gabriella Vita, Camillo Marra, Marcello D'Ascenzo, Claudio Grassi
来源:
Protein & Cell
摘要:
成人海马神经发生的减少是阿尔茨海默病 (AD) 的早期关键事件,导致进行性记忆丧失和认知能力下降。核孔蛋白 153 (Nup153) 是 NSC 干性的关键表观遗传调节因子,其水平降低表征了从 AD (3×Tg) (AD-NSC) 小鼠模型中分离出的神经干细胞,并确定了它们改变的可塑性和基因表达。Nup153 -研究了有助于NSC功能的调节机制:(1)通过蛋白质组学从AD和野生型(WT)小鼠中分离培养的NSC; (2) 通过慢病毒介导将 Nup153 或 GFP 递送到 AD 小鼠和对照小鼠的海马体内,分析神经发生和认知功能; (3) 从 AD 患者和对照受试者获得的人类 iPSC 衍生的脑类器官作为神经发育模型。蛋白质组学方法鉴定了 WT-和 AD-NSC 中的 Nup153 相互作用因子,可能与神经发生调节有关。基因本体(GO)分析表明,WT-NSC 中的 Nup153 结合蛋白参与 RNA 代谢、核输入和表观遗传机制。 AD-NSC 中的 Nup153 结合蛋白参与神经变性、线粒体功能障碍、蛋白酶体加工和 RNA 降解的途径。此外,AD-NSC 中 Nup153 水平的恢复降低了氧化应激标记物的水平并恢复了蛋白酶体活性。慢病毒介导的 AD 小鼠海马微环境中 Nup153 的递送增加了早期祖细胞的增殖,以 BrdU/DCX 和 BrdU/PSANCAM 阳性为标志,以及随后细胞颗粒层中分化神经元(BrdU/NeuN 细胞)的整合与注射 GFP 的 AD 小鼠相比。一致的是,通过莫里斯水迷宫评估,在病毒递送后 1 个月,注射 Nup153 的 AD 小鼠与 AD-GFP 小鼠相比,表现出认知能力的改善。为了验证 Nup153 在神经发生中的作用,我们利用了源自 AD-iPSC 的脑类器官,其特征是神经上皮祖细胞环较少,分化区域减少。 AD 类器官中 Nup153 的上调恢复了神经样管的形成和分化。我们的数据表明,Nup153 对神经发生的积极作用是基于由 Nup153 精心策划的复杂调节网络,并且该蛋白是一个有价值的疾病靶标。© 2024。作者。
Reduction of adult hippocampal neurogenesis is an early critical event in Alzheimer's disease (AD), contributing to progressive memory loss and cognitive decline. Reduced levels of the nucleoporin 153 (Nup153), a key epigenetic regulator of NSC stemness, characterize the neural stem cells isolated from a mouse model of AD (3×Tg) (AD-NSCs) and determine their altered plasticity and gene expression.Nup153-regulated mechanisms contributing to NSC function were investigated: (1) in cultured NSCs isolated from AD and wild type (WT) mice by proteomics; (2) in vivo by lentiviral-mediated delivery of Nup153 or GFP in the hippocampus of AD and control mice analyzing neurogenesis and cognitive function; (3) in human iPSC-derived brain organoids obtained from AD patients and control subjects as a model of neurodevelopment.Proteomic approach identified Nup153 interactors in WT- and AD-NSCs potentially implicated in neurogenesis regulation. Gene ontology (GO) analysis showed that Nup153-bound proteins in WT-NSCs were involved in RNA metabolism, nuclear import and epigenetic mechanisms. Nup153-bound proteins in AD-NSCs were involved in pathways of neurodegeneration, mitochondrial dysfunction, proteasomal processing and RNA degradation. Furthermore, recovery of Nup153 levels in AD-NSCs reduced the levels of oxidative stress markers and recovered proteasomal activity. Lentiviral-mediated delivery of Nup153 in the hippocampal niche of AD mice increased the proliferation of early progenitors, marked by BrdU/DCX and BrdU/PSANCAM positivity and, later, the integration of differentiating neurons in the cell granule layer (BrdU/NeuN+ cells) compared with GFP-injected AD mice. Consistently, Nup153-injected AD mice showed an improvement of cognitive performance in comparison to AD-GFP mice at 1 month after virus delivery assessed by Morris Water Maze. To validate the role of Nup153 in neurogenesis we took advantage of brain organoids derived from AD-iPSCs characterized by fewer neuroepithelial progenitor loops and reduced differentiation areas. The upregulation of Nup153 in AD organoids recovered the formation of neural-like tubes and differentiation.Our data suggest that the positive effect of Nup153 on neurogenesis is based on a complex regulatory network orchestrated by Nup153 and that this protein is a valuable disease target.© 2024. The Author(s).